Landry Benjamin (CIK 1975281) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Sell HCAT (13,779 shares), Sell HCAT (20,838 shares), Buy HCAT (289,000 shares), Buy HCAT (16,473 shares), Sell HCAT (6,317 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 13,779 | $18,880 |
| 2026-03-05 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 20,838 | $34,591 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | General Counsel | Buy | 289,000 | $0 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | General Counsel | Buy | 16,473 | $0 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 6,317 | $11,055 |
| 2025-12-09 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 27,425 | $72,402 |
| 2025-12-03 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 14,387 | $41,722 |
| 2025-09-09 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 6,175 | $20,686 |
| 2025-09-04 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 3,138 | $10,544 |
| 2025-06-09 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 6,057 | $23,865 |
| 2025-06-03 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 3,255 | $11,816 |
| 2025-03-10 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 13,827 | $62,913 |
| 2025-03-04 | Health Catalyst, Inc. (HCAT) | General Counsel | Sell | 9,024 | $41,330 |
| 2025-02-24 | Health Catalyst, Inc. (HCAT) | General Counsel | Buy | 97,500 | $0 |
| 2025-02-24 | Health Catalyst, Inc. (HCAT) | General Counsel | Buy | 13,538 | $0 |
Source: SEC Form 4 filings · as of 2026-06-03